Chemical formula: C₂₅H₃₉N₃O₈ Molecular mass: 509.6 g/mol PubChem compound: 114905
Landiolol is indicated for:
Population group: only adults (18 years old or older)
Supraventricular tachycardia and for the rapid control of ventricular rate in patients with atrial fibrillation or atrial flutter in perioperative, postoperative, or other circumstances where short-term control of the ventricular rate with a short acting agent is desirable.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Population group: only adults (18 - 65 years old)
Non-compensatory sinus tachycardia where, in the physician’s judgment the rapid heart rate requires specific intervention.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Landiolol is contraindicated in the following cases:
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.